💊
Oportuzumab monatox DLRC Pharma Services
oportuzumab monatox
Urologiske neoplasmer;Urinblære-neoplasmer
🚫 Tilbagekaldt
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Treatment and prevention of recurrence of carcinoma-in-situ (CIS) of the urinary bladder and prevention of recurrence of high grade Ta and/or T1 papillary tumours
⚠️ Patient sikkerhed
No